Holen Sie sich die Stockscreener-App
58.50
0.27%
-0.16
Handel nachbörslich:
58.49
-0.010
-0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$58.66
Offen:
$59.16
24-Stunden-Volumen:
1.14M
Relative Volume:
0.48
Marktkapitalisierung:
$9.15B
Einnahmen:
$1.22B
Nettoeinkommen (Verlust:
$81.07M
KGV:
113.79
EPS:
0.5141
Netto-Cashflow:
$223.02M
1W Leistung:
+5.96%
1M Leistung:
+15.04%
6M Leistung:
-1.81%
1J Leistung:
+14.55%
1-Tages-Spanne:
$58.09
$59.78
1-Wochen-Bereich:
$53.44
$60.44
52-Wochen-Spanne:
$46.01
$72.16
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
612-379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.50 | 9.18B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.85 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sumitomo Mitsui Trust Group Boosts Stake in Bio-Techne - National Today
Massachusetts Financial Services Co. MA Has $235.99 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Q1 2026 Bio-Techne Corp Earnings Call Transcript - GuruFocus
Traders Bet Big on Bio-Techne Decline with Put Options Surge - National Today
Traders Purchase High Volume of Put Options on Bio-Techne (NASDAQ:TECH) - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp Stock - National Today
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Stock - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
April McClain Delaney makes multiple trades in Bio-Techne, BJ’s Wholesale, and Nasdaq - Investing.com
Sivik Global Healthcare LLC Takes $2.65 Million Position in Bio-Techne Corp $TECH - MarketBeat
Precision Trading with Bio-techne Corp (TECH) Risk Zones - Stock Traders Daily
Bio-Techne (TECH) SVP exercises 2,259 RSUs, 740 shares withheld - Stock Titan
How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story - simplywall.st
FOMO Trade: How much upside does Bio Techne Corporation haveWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Bio-Techne (TECH) Stock Sees Analyst Price Target Downgrade | TECH Stock News - GuruFocus
Tudor Investment Corp Acquires $13.5M Stake in Bio-Techne - National Today
242,016 Shares in Bio-Techne Corp $TECH Acquired by Tudor Investment Corp ET AL - MarketBeat
TECH Should I Buy - Intellectia AI
Bio-Techne Corporation (TECH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne Corp (1TECH.MI) Analyst Insights, Price Targets & Recommendations - ca.finance.yahoo.com
Assessing Bio-Techne (TECH) Valuation After COMET Spatial Biology Platform Expansion - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
SG Americas Securities LLC Acquires 126,702 Shares of Bio-Techne Corp $TECH - MarketBeat
ETF Watch: What are the future prospects of Bio Techne Corporation2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Small-MidCap Dividend Income Fund's Bio-Techne Corp(TECH) Holding History - GuruFocus
SPYRE Focus Panel launch fails to lift Bio-Techne stock amid pronounced bearish momentum - Traders Union
Fort Washington Investment Advisors Reduces Stake in Bio-Techne - National Today
Fort Washington Investment Advisors Inc. OH Sells 146,767 Shares of Bio-Techne Corp $TECH - MarketBeat
Technical Reactions to TECH Trends in Macro Strategies - Stock Traders Daily
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Riverbridge Partners LLC Has $46.21 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Vanguard disaggregates holdings, reports 0% in Bio‑Techne (NASDAQ: TECH) - Stock Titan
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks - Yahoo Finance
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal
Bio-Techne expands spatial biology product portfolio - Investing.com
Bio-Techne expands spatial biology product portfolio By Investing.com - Investing.com UK
Bio-Techne adds tools aimed at harder-to-detect tissue targets - Stock Titan
Bio-Techne Sees Unusually Large Options Volume (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock rises Monday, still underperforms market - MarketWatch
Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat
JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today
JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat
38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat
After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Barchart.com
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bio Techne Corp-Aktie (TECH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Feb 17 '26 |
Sale |
59.10 |
1,976 |
116,791 |
200 |
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):